|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.09 CAD | -5.26% |
|
0.00% | -18.18% |
| Apr. 02 | MedMira Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2024 | CI |
| Mar. 27 | Samsung Pay to stop working with Russia's Mir payment system from April 3 | RE |
MedMira Inc. has appointed Dr. Philippe Dro as its representative on the company's Board of Directors, effective as of August 7, 2015. Dr. Dro replaces Dr. Michael Sidler who has served on MedMira's Board since 2012. Most recently Dr. Dro was the Chief Executive Officer and member of the supervisory board of GlycoVaxyn AG.
Previous to GlycoVaxyn, Dr. Dro was Chairman and Chief Executive Officer of Endoart SA.
| 1st Jan change | Capi. | |
|---|---|---|
| -18.18% | 46.39M | |
| +12.50% | 228B | |
| +14.52% | 196B | |
| +17.51% | 141B | |
| +28.96% | 110B | |
| +1.37% | 65.88B | |
| +18.16% | 54.3B | |
| +7.63% | 52.39B | |
| +10.95% | 45.22B | |
| +5.10% | 37.12B |
MEDMIRA INC. 
